AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Episode 24. ASCO/EHA 2023 Special: Updates on CAR T-cell Therapy in Myeloma
Blood Cancer Talks
The Disadvantages of Loss of GPRC-5D Expression
In GPRC-5D CAR-T, four out of six patients who progressed after having an initial response had no GPRC. expression at progression. This is in contrast to what the BCMA CAR-T experience where, again, as we described in others, most of the time BCMA may go down but comes back up. And so, I wonder if we may see more sort of escape mutants with loss of GPRC.-5D. But it's a little early. It's probably still speculation. We actually don't have a function at all.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode